Effectiveness of bevacizumab beyond progression in patients with metastatic colorectal cancer – data from the clinical TKK registry. 6. Juni 2014 Schnell, R., Musch, R., Broszeit-Luft, S., Harde, J., Kopfmann, S., Jänicke, M., Marschner, N., 2014. Oncol Res Treat 37(Suppl.5)(V332), 101. doi:10.1159/000368945 Abstract Patients with brain metastases from advanced or metastatic renal cell carcinoma – Data from the clinical RCC Registry. Müller, L., Goebell, P., Reichert, D., Krieger, J., Jänicke, M., Harde, J., Koska, M., Marschner, N., 2014. Oncol Res Treat 37 (suppl.5)(P287), 91. doi:10.1159/000368945… Weiterlesen Real-life treatment and outcome data for patients with advanced NSCLC receiving treatments containing bevacizumab – data from the clinical registry on lung cancer (TLK). Steffens, C.-C., Tessen, H.W., Losem, C., Münz, M., Jänicke, M., Spring, L., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(P217), 64. doi:10.1159/000368945… Weiterlesen